CBRE vs GMED · P/E 43, rev $21.75B vs P/E 42, rev $1.55B
CBRE Group Inc Class A (CBRE) versus Globus Medical (GMED) — a side-by-side from cached financials, not a winner call.
CBRE Group Inc Class A (CBRE) is a real estate services company listed on US.
Globus Medical (GMED) is a medical devices company listed on US.
Latest reported CBRE revenue for 2026-06-30 was $21.75B. Net income was $522.0M. CBRE currently screens at market cap $41.66B and trailing P/E 42.7.
Latest reported GMED revenue for 2026-06-30 was $1.55B. Net income was $275.9M. GMED currently screens at market cap $7.66B and trailing P/E 42.1.
CBRE currently screens at market cap $41.66B and trailing P/E 42.7. GMED currently screens at market cap $7.66B and trailing P/E 42.1.
Not investment advice. Open the CBRE and GMED stock pages for the full models.
Not investment advice.